Gregory Reeder is a healthcare executive with 20+ years of experience in the Rx and OTC industries across diverse domestic and international geographies.
In August 2021, he was appointed CEO of Medterra, a fast-growing global leader in the CBD market.
Prior professional highlights include a series of executive roles, including Senior Vice President of Pfizer’s $2 billion Global Wellness Franchise, Vice President and General Manager for Pfizer Consumer Canada, and Country Manager of Pfizer Romania. Greg started his career at P&G and then Pfizer in brand management with progressive commercial leadership roles, including three multi-billion dollar brands (Lipitor, Effexor, Actonel).
In addition, Greg has served in numerous leadership capacities beyond core business responsibilities, including President of Romania PhRMA association and the Executive Council for Pfizer Diversity & Inclusion.
From an education standpoint, Greg earned both his Ph.D. and M.S. degrees in Chemistry from the University of Cincinnati and a B.S. in Chemistry from Berea College.